It is produced by the strain of Streptomyces cirratus 12090. Cirramycin A1 has anti-gram-positive and negative bacterial activity, it is also effective against a variety of mycoplasmas, the minimum inhibitory concentration against mycoplasmas pneumonia is 0.001 μg/mL.